Clinical trial

Drug Interaction Study Between Dolutegravir and Prednisone

NCT01425099

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE1

Study timeline

Study start (unknown)2011-09-01Date precision: month

Registry last updated2011-11-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Infection, Human Immunodeficiency Virusunresolved

Interventions

DolutegravirDRUG · verified · RxNorm: dolutegravir

PrednisoneDRUG · verified · RxNorm: prednisone

Sponsors & collaborators

ViiV Healthcarelead sponsor

Shionogicollaborator

GlaxoSmithKlinecollaborator

Mapped research locations

BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01425099 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.